Like Costco, Walmart will sell Medicare Advantage plans

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Financial Intelligence • Markets • World News • Independent Analysis
Published: 2026-09-16 • Permanent link

Mega-retailer Walmart is poised to shake up the Medicare Advantage market with a new partnership, selling the plans as part of its expanding healthcare offerings. The deal marks a significant foray into the non-profit health insurer's territory, with Walmart partnering with UnitedHealthcare Community Plan, a nonprofit health insurer that operates in several states. According to reports, the partnership will enable Walmart to offer Medicare Advantage plans to eligible customers, with the company reportedly committing to invest tens of millions of dollars in the venture. The move has sent shockwaves through the healthcare industry, with analysts predicting a potential boost to Walmart's bottom line.

As the news sends ripples through the market, investors are taking notice, with some analysts warning that the deal could lead to increased competition in the Medicare Advantage space. The prospect of a retail giant like Walmart entering the fray has raised concerns among some industry players, who fear that the company's scale and resources could give it a significant advantage. However, others see the move as a positive development, arguing that Walmart's entry into the market could drive down costs and improve access to healthcare for millions of Americans. The result: a potential boon to the economy.

Walmart's foray into the Medicare Advantage market is part of a broader trend of consolidation in the healthcare industry, with several major players vying for control of the market. According to a report by the Kaiser Family Foundation, the Medicare Advantage market is expected to continue growing in the coming years, with some analysts predicting that the market could reach $1 trillion by 2025. Experts say that Walmart's entry into the market is a sign of the company's growing commitment to healthcare, which is expected to play a major role in the company's long-term strategy.

The partnership is likely to be closely watched by regulators, who will be scrutinizing the deal to ensure that it complies with existing laws and regulations. As the deal moves forward, investors will be keeping a close eye on Walmart's financials, with some analysts predicting that the company's investment in the venture could pay off handsomely. However, others warn that the deal is fraught with risks, including the potential for regulatory challenges and increased competition in the Medicare Advantage space. With the deal expected to close later this year, investors will be eagerly awaiting the next development.